Introduction {#S1}
============

Physiological processes occur sequentially in discrete compartments of mammalian organs, such as digestion and absorption along the digestive tract, and filtration, absorption and secretion in the kidney. Compartment boundaries separate cells of different types and may constitute a unique environment for cell signaling. The mammalian lung is a tree-like structure consisting of two compartments: the conducting airways, which filter inhaled air and allow its passage into the distal lung by convection, and the gas exchange region, which undergoes structural specialization into alveoli that drastically increases surface area to facilitate the diffusion of oxygen and carbon dioxide. Both compartments consist of morphologically and molecularly distinct cell types required for their respective functions, including ciliated cells and Clara cells in the conducting airways and alveolar type I and type II cells in the gas exchange region ^[@R1]^. Classic electron and light microscopy studies in multiple species have identified a discrete junction between these two epithelial compartments termed the bronchoalveolar duct junction (BADJ), which is characterized by an abrupt transition in cell type and morphology ^[@R2]--[@R5]^. Recent studies have highlighted the importance of the BADJ as the niche for bronchoalveolar stem cells (BASCs) that express markers of both compartments and are potentially responsible for certain types of lung repair and lung cancer ^[@R6]--[@R8]^.

In relatively simpler systems with limited number of compartment boundaries, it is well established that compartment boundaries form in response to a gradient of diffusible proteins (morphogen gradient) or a combination of a morphogen gradient and an oscillating signal, and can be further refined through differential cell adhesion ^[@R9]--[@R12]^. For example, classic studies show that the anterior and posterior compartments in a Drosophila embryo are marked by restricted expression of *Hunchback* in the anterior compartment, and that this compartment boundary results from localized production of *Bicoid* at the anterior pole, which diffuses posteriorly to form a concentration gradient and exceeds a threshold only in the anterior compartment to activate *Hunchback* expression ^[@R13]^.

In contrast, little is known about when and how compartment boundaries form in complex mammalian organs. The BADJ along the proximal-distal axis of the respiratory tree is analogous to the aforementioned compartment boundary along the anterior-posterior axis in the Drosophila embryo. However, the BADJ has several unique features. First, rather than a single compartment boundary, the BADJ forms at hundreds of locations throughout a respiratory tree and formation of these BADJs requires some level of coordination so that each air passage leads to a properly-sized gas exchange compartment. Second, the respiratory tree is a three-dimensional, hierarchical tubular network; therefore, the signal specifying the BADJ needs to operate within such a spatial complexity. Third, unlike boundary formation in preformed syncytial Drosophila embryos, BADJ formation occurs in the context of an intricate branching morphogenesis process that starts after the left and right lung buds emerge from the embryonic foregut ^[@R1]^. Although a branch lineage has been determined for the airways formed during the first five of nine (E11 to E19) days of embryonic lung development in mice ^[@R14]^, it is unclear how late lung development proceeds, and how the BADJ and gas exchange region relate to the branch lineage. Recent lineage tracing studies suggest that the developing lung has multipotent epithelial progenitors that give rise to cells in the conducting airway and gas exchange compartments depending on developmental stage ^[@R15]^. However, it is unclear how regulation of the multipotent epithelial progenitors is integrated with branching morphogenesis and BADJ formation. Given these unique features of the BADJ, it is unknown whether a spatial signal similar to the morphogen gradient in the Drosophila embryo is used to establish the hundreds of BADJs within the complex three-dimensional respiratory tree.

Using 3D fluorescence imaging, we molecularly defined the BADJ in three-dimensions (3D) and traced the developmental history of the entire respiratory tree. We show that the two compartments are built in two waves --- a first wave of branching morphogenesis followed by a second wave of conducting airway differentiation, and that the boundary between the two compartments, the BADJ, is specified temporally by a global hormone that terminates the second wave and promotes the formation of the gas exchange compartment. Therefore two nested developmental waves set a compartment boundary under the control of a temporal signal.

Results {#S2}
=======

Three dimensional definition of the BADJ in the mature lung {#S3}
-----------------------------------------------------------

The BADJ, historically demarcated by histological and functional criteria, is not well defined in the context of the three-dimensional respiratory tree. Therefore, we developed multi-color immunofluorescence whole mount staining and imaging methods to visualize the hundreds of BADJs in the entire lung at both macroscopic (whole lung) and microscopic (single cell) levels. Since no known gene is expressed only at the BADJ, we visualized the BADJ by staining for the complete conducting airways, similar to how the compartment boundary was marked by *Hunchback* expression in the anterior Drosophila embryos. We chose SOX2, a transcription factor expressed by cells in the conducting airways, instead of markers of differentiated conducting airway cells, such as CCSP (Clara cell secretory protein), because SOX2 is expressed early in development and is necessary and sufficient for conducting airway cell maturation ^[@R16]--[@R20]^, and because CCSP is limited to a subpopulation of conducting airway cells (Clara cells) and to the mature lung, and CCSP lineage positive cells have been identified in both epithelial compartments ^[@R7],[@R21],[@R22]^. When we stained mature lungs for SOX2, all conducting airways were labeled continuously from the trachea ([Fig. 1a](#F1){ref-type="fig"}), and the distal boundary of SOX2 staining coincided with those of CCSP and SMA (smooth muscle actin), a marker for smooth muscles surrounding the conducting airways.

This SOX2 staining pattern ([Fig. 1a](#F1){ref-type="fig"}) and our subsequent cellular analysis ([Fig. 1b](#F1){ref-type="fig"}) allowed us to define the BADJ as the distal boundary of the SOX2 expression domain and to visualize the 3D morphology of the BADJ in the whole lung. SOX2-positive epithelial cells formed a continuous sheet from the trachea, stopping abruptly at the BADJ with no isolated SOX2 positive cells in the gas exchange region. However, the shape of the BADJ is highly irregular around the perimeter of individual terminal bronchioles --- the most distal branches of the conducting airways --- such that a patch of SOX2 positive cells frequently protruded further distally than the rest of the conducting airway with both convex and concave borders ([Fig. 1](#F1){ref-type="fig"}), forming peninsulas (but never islands) of SOX2 positive cells. This irregular shape was not apparent in prior studies of sagittal sections ^[@R23]^ and may contribute to the existence of the respiratory bronchiole --- a hybrid lung tube with properties of both the conducting airway and gas exchange region that appears on sections as an air-conducting tube with its wall interrupted by pouches of alveoli ^[@R3],[@R4],[@R24]^. Depending on the local shape of the BADJ and the section plane, a conducting airway continuous in 3D could appear interrupted by alveolar cells on sections ([Fig. 1c](#F1){ref-type="fig"}), and a single conducting airway appeared as either a terminal bronchiole or a respiratory bronchiole on adjacent sections ([Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}).

The molecular definition of the BADJ as the distal boundary of the SOX2 expression domain matched the classic cellular and morphological definitions of the BADJ as the boundary between cells in the conducting airways and gas exchange region. Clara cells, ciliated cells and neuroendocrine cells, but not basal cells, were found at the BADJ ([Fig. 1](#F1){ref-type="fig"} and [Supplementary Fig. 1b--d](#SD1){ref-type="supplementary-material"}), supporting that SOX2 expression marks a domain of the respiratory tree within which all four cell types of the conducting airway reside. Conversely, SOX2 was not expressed by alveolar type I cells marked by GP38 and RAGE and type II cells marked by SFTPC ([Fig. 1b](#F1){ref-type="fig"} and [Supplementary Fig. 1e, f](#SD1){ref-type="supplementary-material"}); and the compact cell arrangement of the conducting airway stopped at the boundary of the SOX2 expression domain, as shown by ECAD (E-cadherin, an epithelial cell junction marker) staining and bright field imaging ([Fig. 1b, c](#F1){ref-type="fig"} and [Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}). We also examined SOX2 expression in the potential lung stem cells (the BASCs) and observed several low-SOX2-expressing cells at the BADJ that were double positive for CCSP and SFTPC ([Fig. 1](#F1){ref-type="fig"} and [Supplementary Fig. 1g](#SD1){ref-type="supplementary-material"}) and therefore were the BASCs ^[@R6]^. Due to their low frequency, the BASCs were not included in subsequent analyses.

A first wave generates both compartments {#S4}
----------------------------------------

Next, we examined the developmental origin of the BADJs by following SOX2 expression during lung development. To visualize and compare the 3D structures of developing lungs whose sizes change by one order of magnitude, we used a 3D microscopic technique, optical projection tomography (OPT) ^[@R25]^. We imaged whole lungs harvested throughout embryonic development (E10 through E19) and immunostained for three potentially informative markers: ECAD, an epithelial marker; SOX2, a marker for the conducting airways in the mature lung; and SOX9, a marker associated with the distal lung epithelium undergoing branching morphogenesis in early development ^[@R26]--[@R28]^. Our 3D images ([Fig. 2a](#F2){ref-type="fig"}) allowed us to construct a complete developmental series of the entire respiratory tree, including the conducting airways and gas exchange region as well as the BADJs, and examine how the proximal-distal (SOX2--SOX9) patterning in the early developing lung was transformed into the two compartments in the mature lung.

As early as lung specification at E10, SOX9 expression started in the nascent lung buds in the anterior foregut ([Fig. 2a](#F2){ref-type="fig"}). Consistent with previous reports ^[@R26]--[@R28]^, SOX9 was invariably associated with the distal epithelium generating new branches early in development (before E15). Surprisingly, we found that this branching process continued throughout embryonic development even during the canalicular and saccular stages of lung development (E18 and E19 ^[@R29]^) ([Fig. 2a, b](#F2){ref-type="fig"} and [Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}). New branches at early (E14) and late (E17) stages were formed by a similar process: both were simple epithelia ([Fig. 2c](#F2){ref-type="fig"}); activated the ERK (extracellular signal-regulated kinase) signaling ([Fig. 2d](#F2){ref-type="fig"}) and branching related genes, such as *Fgfr2*, *Bmp4*, *Spry2*, *Id2*, *Thbs1*, *Lamc1* and *Pcsk6* ([Fig. 2e](#F2){ref-type="fig"} and [Supplementary Fig. 2b, c](#SD1){ref-type="supplementary-material"}); recruited smooth muscles ([Supplementary Fig. 2d](#SD1){ref-type="supplementary-material"}) and co-aligned with the vasculature ([Supplementary Fig. 2e](#SD1){ref-type="supplementary-material"}).

As described in detail below, among all the branches generated via this continuous branching process, some became the conducting airways while others became the gas exchange region. Therefore, despite the grossly different structures and functions of the two compartments, both are formed by a similar and continuous process of branching morphogenesis, which we refer to as the first developmental wave --- the branching morphogenesis wave (the SOX9 wave), by analogy to the centrifugal expansion of a physical wave from a point source (the equivalent of the trachea).

A second wave establishes the BADJs {#S5}
-----------------------------------

New branches left behind by the first wave stopped expressing SOX9 and activated SOX2 in early development (before E15, [Fig. 2a](#F2){ref-type="fig"}). SOX2 expression persisted and marked the conducting airways in the mature lung, and appeared to be the earliest event of conducting airway differentiation; this, together with the role of *Sox2* in promoting mature conducting airway cells ^[@R16]--[@R20]^, led us name this centrifugal expansion of SOX2 expression the second developmental wave --- the conducting airway differentiation wave (the SOX2 wave).

While the expansion of SOX9 and SOX2 expression domains were coupled in early development, such a coupling was interrupted at E17 --- progression of the SOX2 wave was terminated while the SOX9 wave was still progressing, generating a large gap between the two wave fronts ([Fig. 2a](#F2){ref-type="fig"}). After E17, newly generated branches did not express SOX2 or contribute to the conducting airways, which grew with an increase only in length and diameter but not in branch number. Such independent progression of the two waves was more clearly demonstrated by counting branch tips and termini at the front of the SOX9 and SOX2 waves, respectively ([Fig. 2b](#F2){ref-type="fig"}). The number of SOX9-positive tips increased exponentially throughout embryonic development, reflecting the continuous progression of the branching morphogenesis wave, whereas the number of SOX2-positive termini increased early in development but plateaued at E17, reflecting the completion of new conducting airways and therefore the formation of the BADJ. This divergence of the number of SOX2 termini from that of SOX9 tips ([Fig. 2b](#F2){ref-type="fig"}) is unexpected from simple extrapolation of the known proximal-distal patterning of early developing lungs to late developmental stages, which will predict a parallel increase in the numbers of SOX2 termini and SOX9 tips throughout development.

The uncoupling between the two waves was supported by *Sox9^CreER^* lineage tracing experiments showing that SOX9 expressing cells in the first wave contributed significantly to the second wave before, but not after, E15 ([Supplementary Fig. 3a, b](#SD1){ref-type="supplementary-material"}), a finding consistent with previous *Id2^CreER^* lineage tracing results ^[@R15]^. These data, together with the branch counting results showing that the number of SOX9-positive tips reached the maximal number of SOX2-positive termini at E15 ([Fig. 2b](#F2){ref-type="fig"}), suggested that cells near the BADJ are present at the very distal region of branch tips at E15, and that during the next two days some daughter cells become branch stalks, lose SOX9 expression and activate SOX2 at the BADJ at E17.

The developmental origin of the BADJ was corroborated by *Sox2^CreER^* lineage tracing experiments showing that the second wave marker SOX2 prospectively marked the conducting airways and the BADJ, but not the gas exchange region, in the mature lung. As predicted in our model ([Fig. 3b](#F3){ref-type="fig"}), when recombination was induced early in development (before E17) while the SOX2 wave was still progressing, the lineage-labeled cells were distributed in a gradient within the conducting airways in the mature lung with high cell density proximally and low cell density distally ([Fig. 3](#F3){ref-type="fig"} and [Supplementary Fig. 3c](#SD1){ref-type="supplementary-material"}). When recombination was induced late in development, at or after the time of BADJ formation (E17), the lineage-labeled cells were evenly distributed along the proximal/distal axis of the mature conducting airways. Furthermore, the distal boundary of lineage-labeled cells in the mature lung progressed uniformly along all ramifications of the conducting airways as a function of the time of the lineage-labeling ([Fig. 3](#F3){ref-type="fig"} and [Supplementary Fig. 3c](#SD1){ref-type="supplementary-material"}). Importantly, the BADJs in the mature lung were lineage labeled when recombination was induced at or after E17 ([Fig. 3d](#F3){ref-type="fig"} and [Supplementary Fig. 3d](#SD1){ref-type="supplementary-material"}), the same time predicted for BADJ formation based on our quantitative analysis of fixed lungs ([Fig. 2a, b](#F2){ref-type="fig"}). The *Sox2^CreER^* lineage tracing experiments also excluded the possible model where the conducting airways and the BADJ form simply as a result of proliferation and distal expansion of existing SOX2 positive cells without conversion of newly formed branches to the conducting airways, which predicts that the BADJ should be lineage-labeled much earlier than observed.

Therefore, a second wave of conducting airway differentiation marked by SOX2 expression, follows, but terminates earlier than, the first wave to establish the BADJs ([Fig 3b](#F3){ref-type="fig"}). From the viewpoint of branching morphogenesis, the non-branching epithelium left behind by the first wave becomes SOX2-positive conducting airways early in development but becomes SOX2-negative alveolar cells late in development --- a temporal switch in cell fate that sets the BADJ.

Role of candidate morphogens in the two waves {#S6}
---------------------------------------------

We reasoned that if a spatial signal such as a morphogen gradient specifies the BADJ in the developing lung, the morphogen may originate in either a proximal or distal location and decrease gradually along the proximal-distal axis ([Supplementary Fig. 4a, b](#SD1){ref-type="supplementary-material"}). Although a morphogen produced distally, such as *Fgf10* ^[@R1]^, may limit the progression of the SOX2 wave early in development. However, it is not obvious why the SOX2 wave stops at E17, and does not keep following the continuous progression of the first wave and the putative distal morphogen gradient after E17 ([Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}). Alternatively, similar to *Bicoid* in the Drosophila embryo ^[@R13]^, a morphogen produced proximally can promote SOX2 expression (the second wave) and fall below a functional threshold at the BADJ as the respiratory tree grows during development --- a model likely depending on precise regulation of branch size and generation ([Supplementary Fig. 4b](#SD1){ref-type="supplementary-material"}).

We first examined the roles of candidate morphogens in the *Fgf*, *Wnt* and *Bmp* signaling pathways in the progression of the two developmental waves and the formation of the BADJ. To distinguish their roles in the progression versus termination of the SOX2 wave, we used *Sox9^CreER^* to specifically target early (E12 to E15) or late (E15 to E18) development. When we expressed a hyperactive *Kras* allele or deleted *Ctnnb1* to alter receptor tyrosine kinase (including *Fgf*) or *Wnt* signalings, the first wave was affected in both early and late development ([Fig. 4a](#F4){ref-type="fig"}). Specifically, *Kras* mutant branches were overgrown with expanded SOX9 expression and *Ctnnb1* mutant branches mostly lost SOX9 expression. Therefore, consistent with our conclusion that the two epithelial compartments are generated by a continuous wave of branching morphogenesis ([Fig. 2](#F2){ref-type="fig"}), *Fgf* and *Wnt* signalings regulate the first wave in a similar way in both early and late lung development.

In contrast, the effects of early versus late gene targeting on the SOX2 wave were different. While early targeting of the *Kras*/*Fgf* or *Ctnnb1*/*Wnt* signaling led to a restricted or expanded SOX2 expression domain respectively, late targeting had little or no effect on SOX2 expression ([Fig. 4a](#F4){ref-type="fig"}). This temporal difference suggested that the role of *Fgf* and *Wnt* signalings in proximal-distal patterning is restricted to early development when the two waves are coupled and that other mechanisms uncouple the two waves to form the BADJ.

Although *Bmp4* has been implicated in proximal-distal patterning of the developing lung ^[@R30],[@R31]^, epithelial deletion of *Bmp4* had no apparent effects in either the first or second wave ([Fig. 4b](#F4){ref-type="fig"}) and the resulting *Bmp4* mutant mice were viable. We note that deletion of *Bmp* receptors disrupts lung specification and branching, suggesting involvement of additional BMP ligands ^[@R32]^. Taken together, these data indicated that alterations of some distal morphogens ([Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}) do not affect termination of the SOX2 wave and BADJ formation.

BADJ formation is independent of branch size and generation {#S7}
-----------------------------------------------------------

Next, we used two different genetic conditions to alter branch number, size and generation, all of which were expected to cause major structural changes and alter the slopes and/or ranges of potential morphogen gradients. In the first condition, lung development was allowed to initiate normally up to E13, and then an *Sftpc-rtTA* and *tetO-DTA* system was used to achieve lung epithelium specific, doxycycline-dependent cell ablation ([Fig. 5a](#F5){ref-type="fig"} and [Supplementary Fig. 5a, b](#SD1){ref-type="supplementary-material"}). We found that epithelial cell ablation disrupted the branching morphogenesis wave and generated fewer and dilated branches. In the second condition, we examined lung development in an organ size mutant (*Igf1r^−/−^*). We found that the *Igf1r* mutant lung initiated and developed normally up to E13, after which the branching morphogenesis wave progressed much more slowly and generated a smaller lung with fewer, albeit normal looking branches ([Fig. 5b](#F5){ref-type="fig"} and [Supplementary Fig. 5c](#SD1){ref-type="supplementary-material"}). In the two genetic conditions, despite opposite changes in the level or distribution of known morphogens including *Fgf10*, *Bmp4* and *Wnt2* ([Supplementary Fig. 5d](#SD1){ref-type="supplementary-material"}), the SOX2 wave continued to progress behind the SOX9 wave and terminated on schedule ([Fig. 5](#F5){ref-type="fig"}). Furthermore, in both conditions, cells in the conducting airways (Clara cells, ciliated cells and neuroendocrine cells) and the gas exchange region (alveolar type I and type II cells) underwent normal differentiation ([Supplementary Fig. 5e, f](#SD1){ref-type="supplementary-material"}). These data suggested a robust mechanism of BADJ formation independent of counting branches or branch generations or a specific spatial signal such as a morphogen gradient that depends on precise spatial organization of the epithelial tree ([Supplementary Fig. 4a, b](#SD1){ref-type="supplementary-material"}).

A temporal glucocorticoid signal specifies BADJ location {#S8}
--------------------------------------------------------

The kinetics of the progression and termination of the SOX2 wave and its resistance to spatial perturbations prompted us to search for a temporal signal that specifies the location of the BADJ. Glucocorticoid signaling was an intriguing candidate because the level of glucocorticoid increases at late gestation stages ^[@R33]--[@R35]^, and we found that normal BADJ formation coincided temporally with an increase in glucocorticoid signaling, as measured by plasma glucocorticoid levels and nuclear localization ^[@R36]^ of glucocorticoid receptor ([Supplementary Fig. 6a, b](#SD1){ref-type="supplementary-material"}). To test the role of glucocorticoid and other hormones, we established an explant culture assay using lungs from genetically engineered mice that allowed us to monitor the progression of the two waves in real time ([Fig. 6a](#F6){ref-type="fig"}). Using this assay, we tested agonists and antagonists of glucocorticoid and other hormones, including retinoic acid and thyroid hormone, that have been implicated in lung development ^[@R37]--[@R40]^. Whereas pharmacological alterations of other hormones had no effect or non-specific toxicity on the cultured lungs, addition of 100 nM dexamethasone, an agonist of glucocorticoid signaling ([Supplementary Fig. 5c](#SD1){ref-type="supplementary-material"}), specifically terminated progression of the second wave without affecting the first wave of branching morphogenesis ([Fig. 6a](#F6){ref-type="fig"}). Microarray expression profiling and immunostaining ([Supplementary Fig. 5d, e](#SD1){ref-type="supplementary-material"} and [Supplementary Data 1](#SD2){ref-type="supplementary-material"}) showed that dexamethasone prematurely activated genes associated with alveolar cell differentiation (*Sftpb*, *Napsa*, *Ctsh*, *Ass1*, *Scnn1a*, *Hopx*, RAGE and AQP1) within one and two days of culture. Notably, alveolar differentiation occurred immediately beyond the distal boundary of the SOX2 expression domain, consistent with premature BADJ formation in a more proximal location. The effects of dexamethasone on both progression of the SOX2 wave and alveolar differentiation were blocked by mifepristone, an antagonist of glucocorticoid signaling ([Supplementary Fig. 5e, f](#SD1){ref-type="supplementary-material"}).

Similarly, when administered in vivo to pregnant mice before BADJ formation, dexamethasone also caused a significant delay in progression of the second wave without affecting the first wave ([Fig. 6b](#F6){ref-type="fig"}). Importantly, the dexamethasone-treated lungs prematurely activated expression of alveolar cell markers (RAGE and AQP1, [Supplementary Fig. 7a, b](#SD1){ref-type="supplementary-material"}) immediately beyond the distal boundary of the SOX2 expression domain, and therefore formed the BADJ at a more proximal location of the epithelial tree ([Fig. 6c](#F6){ref-type="fig"}). The location of cells undergoing premature alveolar differentiation both in culture and in vivo suggested that SOX2-negative cells, but not committed SOX2-positive conducting airway cells, are able to respond to systemic glucocorticoid signaling and differentiate into alveolar cells. The fact that cells normally destined to adopt the conducting airway fate switched to the alveolus fate in response to dexamethasone showed that the cell fate choice between the two compartments, and therefore BADJ location, is determined not by the first wave, but rather the termination of the second wave in response to glucocorticoid signaling. Therefore, when there is a change in the timing of the hormonal signal, there is a corresponding change in the BADJ location.

Conversely, in glucocorticoid receptor mutants (*GR ^−/−^*) in which glucocorticoid signaling is abolished, the second wave was prolonged resulting in an expanded conducting airway compartment and a distal shift of the BADJ location ([Fig. 7a](#F7){ref-type="fig"}). Although the second wave eventually stopped at E19, suggesting the existence of late-acting back-up signals other than glucocorticoids, the formation of the BADJs was not complete because the expression levels of alveolar cell markers (RAGE and AQP1) were lower than those in the control ([Supplementary Fig. 7c, d, e](#SD1){ref-type="supplementary-material"}). Interestingly, the *GR* mutant lung had larger SOX9-positive branch tips than the control lung ([Fig. 7b](#F7){ref-type="fig"}), suggesting that glucocorticoid signaling promotes alveolar differentiation and limits both conducting airway differentiation and SOX9-positive progenitor maintenance. A proliferation marker CCND1 (Cyclin D1) was highly expressed in distal SOX9-positive and proximal SOX2-positive cells, but at a much lower level in differentiated alveolar cells in between ([Fig. 7b](#F7){ref-type="fig"}), supporting the idea that BADJ formation is associated with cell cycle exit and alveolar differentiation of SOX2-negative cells left behind by the first SOX9 wave.

Finally, to examine the direct target cells of glucocorticoid signaling, we genetically deleted GR in either epithelial cells or a majority of mesenchymal cells with *Shh^Cre^* or *Dermo1^Cre^*, respectively ([Supplementary Fig. 8a](#SD1){ref-type="supplementary-material"}). Mesenchymal deletion of GR partially recapitulated the expanded conducting airway compartment phenotype of the *GR* null mice ([Supplementary Fig. 8b](#SD1){ref-type="supplementary-material"}), suggesting compensation by the remaining GR-positive mesenchymal cells and/or cooperation of glucocorticoid signalings in both epithelial and mesenchymal cells ^[@R41]--[@R44]^. Taken together, we conclude that the BADJ is specified by two nested developmental waves under the control of a temporal glucocorticoid signal ([Fig. 7c](#F7){ref-type="fig"}).

Discussion {#S9}
==========

The results support a novel model of compartment boundary formation in the mouse lung: a first wave generates both compartments; a second wave follows the first wave to specify one compartment; and a temporal hormonal signal terminates the second wave to set the compartment boundary. Compartment boundaries including the BADJ are spatial landmarks; their formation is fundamentally the specification of different cell types on the opposite sides of the boundary and their location is often encoded spatially for example by morphogen gradients. However, we show that BADJ formation is due to a temporal switch in cell fate specification --- the non-branching epithelia left behind by the first wave undergo conducting airway differentiation early in development, but alveolar differentiation late in development, and that the location of the BADJ is encoded temporally --- by the timing of a global hormonal signal. Although glucocorticoid signaling is known to promote alveolar differentiation, our study demonstrates its new role in spatial patterning. Our results suggest that the pro-alveolus action of glucocorticoid signaling depends on the absence of SOX2 expression and in part involves mesenchyme-derived soluble ^[@R43]^ and/or matrix proteins ^[@R41],[@R44]^. How these factors impinge on cell cycle exit and alveolar differentiation requires further investigation.

This time-controlled two-wave model has some unique properties in controlling compartment boundary formation in a complex organ. For example, a global temporal signal bypasses the challenges in maintaining a stable morphogen gradient at a time when the shape and size of an organ are highly dynamic, and allows synchronized formation of hundreds of boundaries between two compartments, such as the BADJs. Also, our model contains modular programs that are simpler to encode genetically and to modulate during evolution. For example, to evolve different numbers of branches to match respiratory demand, different species need only adjust the rate of branch generation in the first wave, while the coupling between the timing of the temporal signal and the gestation period, as well as between the respiratory and vascular trees, will ensure a functional and properly proportioned lung at birth. We suggest that, in a structure where one compartment is built upon and therefore after a previously formed compartment, such as the two epithelial compartments of the mammalian lung and vertebrate somites ^[@R12]^, temporal signals may be used in addition to spatial signals or morphogen gradients to specify compartment boundaries.

Our model does not exclude the role of morphogens, including *Fgf*, *Wnt* and *Bmp*, in the first wave and in the coupling of the two waves in early lung development. In fact, the same signaling pathways (e.g. *Fgf* and *Wnt*) are continuously required for the first wave throughout embryonic development. However, the BADJ forms in late lung development apparently independent of these morphogens, but rather in response to a temporal signal. Different from the multipotent progenitor model ^[@R15]^, our model indicates that early and late progenitors share the same branching program and the capability of responding to glucocorticoids, and only start to differ when they become branch stalks and undergo differentiation in response to a global hormonal signal. Our model also suggests that the BASCs are the last cells committed to the conducting airway cell fate when the glucocorticoid signal is activated. Such a developmental history might endow the BASCs the abilities to possibly generate cells of both epithelial compartments under certain injury conditions ^[@R7],[@R45],[@R46]^.

Our findings that branching morphogenesis continues throughout development and generates branches for both epithelial compartments provide new insights into proximal-distal patterning in the lung. Although the spatial distributions of SOX9 and SOX2 have been described in the early developing lung with SOX9 expressed in the distal branching epithelia and SOX2 expressed in the proximal non-branching epithelia ^[@R1]^, this proximal-distal patterning does not simply extend to the late developing lung (after E17). We show that branching morphogenesis continues during late development and leaves behind non-branching epithelia wrapped by smooth muscles and co-aligned with vessels, similar to the proximal non-branching epithelia during early development. These late non-branching epithelia are proximal relative to the distal SOX9 wave, but do not express SOX2 as the early non-branching epithelia do and instead differentiate into alveolar cells. Therefore, the proximal non-branching portion of the respiratory tree in late lung development can be further divided into two parts: SOX2-positive conducting airways most proximally and SOX2-negative alveolar cells in the near distal region. Additional mechanism other than SOX2-proximal/SOX9-distal patterning is necessary to explain why the near distal, non-branching epithelia during late lung development do not activate SOX2. We show that such a mechanism involves a temporal glucocorticoid signaling that terminates the SOX2 wave and sets the BADJ. Our two-wave model is also supported by and predicts the existence of the alveolar duct --- a tubular structure distal to the BADJ made of alveolar cells, which is derived from branches left behind by the first wave during late lung development and undergoing alveolar differentiation in response to the hormonal signal.

Our model suggests mechanism-based therapeutic options for lung defects in premature birth. As the first wave of branching morphogenesis progresses throughout embryonic development, lungs in premature infants will have structural immaturity, such as fewer branches for the gas exchange compartment, in addition to cellular immaturity, such as insufficient surfactant production ^[@R47]^. Since cells at the front of the first wave express the same molecules and signaling genes throughout development, positive and negative regulators of branching in early lung development may also be therapeutic targets for accelerating the branching morphogenesis wave in the perinatal period to compensate for the shorter developmental time in premature births. Although the conducting airways and gas exchange region in the mature lung are distinct compartments separated by the BADJ, their embryonic precursors are surprisingly plastic such that the location of the BADJ can be altered simply by manipulating the timing of the glucocorticoid signal. Such plasticity suggests that the beneficial effects of glucocorticoid therapy in premature birth ^[@R48],[@R49]^ is at least in part through its effect on BADJ position and balancing the proportion of the two compartments.

Methods {#S10}
=======

Mice {#S11}
----

Inbred FVB/NJ (Stock 001800) and C57B6/J (Stock 000664) were obtained from the Jackson Laboratory. Mice carrying *Sox9^CreER^* ^[@R50]^, *Kras^LSL-G12D^* ^[@R51]^, *Sox2^CreER^* ^[@R52]^, *Rosa^mTmG^* ^[@R53]^, *Sox2^EGFP^* ^[@R52]^, *Sftpc-rtTA* ^[@R54]^, *TetO-DTA* ^[@R55]^, *TetO-GFP* ^[@R56]^, *Rosa^tdT^* ^[@R57]^, *Shh^Cre^* ^[@R58]^, *Dermo1^Cre^* ^[@R59]^ alleles have been described. Mice carrying the *Igf1r* ^[@R60]^, GR ^[@R61]^, *Bmp4* ^[@R62]^ or *Ctnnb1* ^[@R63]^ conditional allele were mated to female *HPRT^Cre/+^* mice ^[@R64]^ to generate mice carrying the germ line *Igf1r* null allele (*Igf1r ^−^*, *GR ^−^*, *Bmp4 ^−^* and *Ctnnb1 ^−^*). The resulting null alleles were genotyped using the following primer pairs: 5′-TGAGACGTAGCGAGATTGCTGTA-3′ and 5′-CAGGCTTGCAATGAGACATGGG-3′ (*Igf1r ^−^*); 5′-CTCCTCCATTTTGCGAGC-3′ and 5′-AAGGAGCAGTCACCAACTGTC-3′ (*GR ^−^*); 5′-AGACTCTTTAGTGAGCATTTTCAAC-3′ and 5′-AAGATGCCTGCCAGGACTGA-3′ (*Bmp4 ^−^*); and 5′-CACCATGTCCTCTGTCTATTC-3′ and 5′-TACACTATTGAATCACAGGGACTT-3′ (*Ctnnb1 ^−^*). The day the vaginal plug was observed was designated as E1 and the day the mice were born was designated as P0. For FVB/NJ and C57B6/J mice, the last day of gestation is E19. For *Sox2^CreER^* lineage tracing experiments, 0.45 mg tamoxifen (T5648, Sigma) dissolved in corn oil (C8267, Sigma) was given orally to timed pregnant mice at indicated gestation days and the progeny were allowed to grow to P21 when the lungs were harvested. A higher dose of tamoxifen caused embryonic or neonatal death. We note that although it takes 12--24 hours to observe Cre-dependent reporter expression ^[@R65]^, recombination likely occurs much earlier and is directly relevant to inferring the time of BADJ formation in the long-term *Sox2^CreER^* lineage tracing experiments. For *Sox9^CreER^* lineage tracing and *Kras* activation experiments, 2 mg tamoxifen dissolved in corn oil was given intra-peritoneally to timed pregnant mice. To delete *Ctnnb1* with *Sox9^CreER^*, 3.5 mg tamoxifen dissolved in corn oil was given intra-peritoneally to timed pregnant mice. To activate *Sftpc-rtTA*, timed pregnant mice were given 2 mg mL^−1^ doxycycline (D9891, Sigma) in drinking water from E13 to E14. To activate glucocorticoid signaling, timed pregnant mice were given 0.5 ug mL^−1^ dexamethasone (D2915, Sigma) in drinking water from E12 to E15. At least three independent dexamethasone treatments were carried out with similar results. To measure plasma corticosterone levels, mice were euthanized with carbon dioxide around noon, blood collected in syringes containing 100 uL 0.5 M EDTA (ethylenediaminetetraacetic acid, E9884, Sigma) through inferior vena cava to minimize hemolysis, and corticosterone level measured using an enzyme immunoassay kit (500655, Cayman). All animal experiments were approved by the institutional animal care and use committee (IACUC) at Texas A&M Health Science Center Institute of Biosciences and Technology (protocol number 11004).

Antibodies {#S12}
----------

The following antibodies were used: mouse anti-Acetylated tubulin (AcT, 1:2500, T7451, Sigma), rabbit anti-Aquaporin 1 (AQP1, 1:1000, AB2219, Millipore), rabbit anti-Clara cell secretary protein (CCSP, 1:1000, WRAB-3950, Seven Hills Bioreagents), goat anti-Clara cell secretary protein (CCSP, 1:2500, Dr. Barry Stripp, Duke University), rabbit anti-Calcitonin gene-related peptide (CGRP, 1:500, BML-CA1134, Enzo Life Sciences), rabbit anti-Cyclin D1 (CCND1, 1:500, RM9104S0, ThermoFisher), rabbit anti-Fibroblast growth factor receptor 2 (FGFR2, 1:250, sc-122, Santa Cruz Biotechnology), mouse anti-Forkhead box protein J1 (FOXJ1, 1:100, Dr. Steven Brody, Washington University in St. Louis), chicken anti-Green fluorescent protein (GFP, 1:1000, AB13970, Abcam), rat anti-E-Cadherin (ECAD, 1:1000, 131900, Invitrogen), rabbit anti-glucocorticoid receptor (GR, 1:500, sc-1004, Santa Cruz Biotechnology), hamster anti-Glycoprotein 38 (GP38, 1:250, 8.1.1, Developmental Studies Hybridoma Bank), rat anti-CD31 (PECAM, 1:500, 550274, BD Biosciences), rabbit anti-phospho-ERK1/2 (pERK, 1:250, 4370, Cell Signaling Technology), rat anti- Receptor for advanced glycosylation of end products (RAGE, 1:1000, MAB1179, R&D Systems), Cy3 or FITC conjugated mouse anti-Smooth muscle actin (SMA, 1:1000, C6198 or F3777, Sigma), goat anti-SRY-box containing gene 2 (SOX2, 1:250, sc-17320, Santa Cruz Biotechnology), rabbit anti-SRY-box containing gene 9 (SOX9, 1:1000, AB5535, Millipore), goat anti-SRY-box containing gene 9 (SOX9, 1:1000, AF3075, R&D Systems), rabbit anti-Prosurfactant protein C (SFTPC, 1:1000, AB3768, Millipore).

The goat anti-CCSP antibody, but not the rabbit anti-CCSP antibody, was sensitive enough to label the BASCs under current experimental conditions. Because the SOX2 antibody was also made in goat, GFP expression in the *Sox2^CreER/+^; Rosa^mTmG/+^* and *Sox2^EGFP/+^* mice was used as a surrogate marker of SOX2 for co-labeling with the goat anti-CCSP antibody ([Supplementary Fig. 1g](#SD1){ref-type="supplementary-material"}). The arteries were distinguished from the veins based on their narrow lumen, association with a high density of smooth muscles, proximity to the airway, and connection with the left/right main pulmonary arteries. Fluorescent donkey secondary antibodies were from Invitrogen and Jackson ImmunoResearch and used at 1:1000 dilution. Because there was no donkey anti-hamster secondary antibodies, rabbit or goat secondary antibodies were used for the GP38 antibody ([Supplementary Fig. 1e](#SD1){ref-type="supplementary-material"}).

Tissue preparation and immunostaining {#S13}
-------------------------------------

Three-four week old male and female mice were anesthetized with Avertin (T48402, Sigma) and perfused with PBS (phosphate buffered saline, pH 7.4) through the right ventricle. Lungs were inflated with 0.5% paraformaldehyde (PFA; P6148, Sigma) in PBS at 25 cm H~2~O pressure, and then dissected and fixed with 0.5% PFA in PBS at room temperature for 3 to 6 hours. Embryos were dissected from timed pregnant mice and fixed with 0.5% PFA in PBS at room temperature for 2 to 4 hours. For section immunostaining, the fixed lungs were cryoprotected in PBS with 20% sucrose and 33% Optimal Cutting Temperature Compound (OCT; 4583, Tissue-Tek, Tokyo, Japan, optional for embryonic lungs) at 4°C overnight and then embedded in OCT. Immunostaining of frozen sections and whole lungs was carried out essentially as described ^[@R66]^. Briefly, frozen sections at 10 um thickness were incubated with PBS with 5% normal donkey serum (017-000-121, Jackson ImmunoResearch) and 0.3% Triton X-100, and then incubated with primary antibodies diluted in PBS with 0.3% Triton X-100 at 4°C overnight. The following day, the sections were washed with PBS for 2 hours at room temperature and then incubated with secondary antibodies and DAPI (4′,6-diamidino-2-phenylindole) diluted in PBS with 0.1% Triton X-100 and 0.1% Tween-20 for 90 minutes at room temperature. The sections were then washed as described above and mounted with Aquamount mounting medium (18606, Polysciences). The FOXJ1 antibody required an antigen retrieval procedure before staining, in which sections were heated in sodium citrate buffer (10 mM sodium citrate, 0.05% Tween 20, pH 6.0) at 95°C for 30 minutes and allowed to cool down at room temperature for an additional 30 minutes. For whole-mount immunostaining, the lungs were dehydrated through a methanol/PBS gradient and bleached with 6% hydrogen peroxide in methanol at 4°C overnight. The bleached lungs were rehydrated through a methanol/PBS gradient and incubated with PBS with 5% normal donkey serum and 0.3% Triton X-100, and then incubated with primary antibodies diluted in PBS with 0.3% Triton X-100 at 4°C overnight. The following day, the lungs were washed in PBS with 1% Triton X-100 and 1% Tween-20 for 6 hours at room temperature and then incubated with secondary antibodies diluted in PBS with 0.3% Triton X-100 at 4°C overnight. The lungs were then washed again and fixed with 4% PFA in PBS at room temperature for 2 to 4 hours. For imaging with a fluorescence stereomicroscope, the lungs were dehydrated through a methanol/PBS gradient, cleared with BABB --- 1 part of benzyl alcohol (24122, Sigma) and 2 parts of benzyl benzoate (B6630, Sigma), and mounted on a depression well slide without a cover slip and with a minimal amount of BABB that was enough to cover the lungs. Images were captured on a fluorescence stereomicroscope with a 2X Plan Apochromat objective (M205C, Leica) or a confocal microscope (FV1000, Olympus).

OPT microscopy {#S14}
--------------

Immunostained whole mount lungs were embedded in 1% low melting agarose (16520-100, Invitrogen), processed and imaged on a Bioptonics 3001 OPT scanner equipped with GFP3, TXR and Cy5 filters (Bioptonics, UK) at a high resolution (1024 pixels) following the manufacturer's instructions. The resulting image stacks were visualized using maximal intensity projection with the Bioptonics Viewer (Bioptonics, UK) or Imaris (Bitplane) software. After the scan, some lung samples were dissected from the agarose block and imaged under a fluorescence stereomicroscope (M205C, Leica).

Quantification of branch tips/termini and cell numbers {#S15}
------------------------------------------------------

All branches of planar bifurcation in the L.L1 through L.L6 branch lineages ^[@R14]^ were counted and these branches were close to the flat edge of the left lobe ([Supplementary Fig. 9](#SD1){ref-type="supplementary-material"}). By combining multiple branch lineages, this branch counting method was robust to account for variations in the branch lineage that might occur as a result of space competition from neighboring branches ^[@R67]^, as well as the non-dichotomous nature of branching in the mouse lung ^[@R14]^. Because branches generated at early gestation stages (before E15) gradually activated *Sox2* and had a high level of SOX2 expression proximally and a low level distally, only branch termini with a high level SOX2 expression were counted. SOX9 and SOX2 expressing branches were close and open-ended and referred to branch tips and termini, respectively. At least three lungs were quantified for each embryonic or postnatal stage examined.

For *Sox2^CreER^* lineage tracing experiments, the conducting airways along the RCr.L1 lineage ^[@R14]^ of P21 lineage-labeled lungs were divided into three regions of equal length and 4 random fields were imaged for each region. To normalize labeling efficiency between mice, the density of GFP positive cells in each region was compared with that in the extra-pulmonary bronchus in the same lung and categorized as high (67--100%), medium (33--67%) or low (0--33%). Due to limited resolution in whole mount imaging, which was necessary to map the labeled cells onto the respiratory tree, precise cell counting was not feasible. At least two independent lineage labeling experiments with similar results were performed for each embryonic stages examined.

Section and whole mount in situ hybridization {#S16}
---------------------------------------------

In situ hybridization was performed essentially as described ^[@R68]^. Digoxigenin-labeled riboprobes (11277073910, Roche) were transcribed with T7 RNA polymerase (18033-019, Invitrogen) from the indicated cDNAs, which were isolated as cloned PCR products derived from mouse embryonic lung RNAs. Embryonic lungs were dissected and fixed in 4% PFA in PBS for 3 to 5 hours at room temperature. For section in situ hybridization, fixed lungs were cryoprotected in PBS with 20% sucrose and 0.4% PFA at 4°C overnight and then embedded in OCT. At room temperature, frozen sections at 10 um thickness were fixed with 4% PFA in PBS for 10 minutes, and then treated with freshly made acetylation solution (diethylpyrocarbonate-treated H~2~O with 0.0133% triethynolamine and 0.0025% acetic anhydride) for 10 minutes. After incubation with hybridization solution (50% formamide, 5x SSC (sodium chloride and sodium citrate), 5X Denhardt's solution, 500 ug uL^−1^ salmon sperm DNA, 250 ug uL^−1^ yeast tRNA) for 1 hour at room temperature, the sections were incubated with 1 ug mL^−1^ riboprobes diluted in hybridization solution in a slide oven (24100, Boekel) at 62°C overnight. The following day, after being washed in 2x SSC for 30 minutes at room temperature and 0.2x SSC for 2 hours at 65°C, the sections were incubated with TBST (100 mM Tris, 150 mM sodium chloride, 0.1% Tween-20, pH 7.5) with 5% normal sheep serum (013-000-121, Jackson ImmunoResearch), and then with anti-digoxigenin alkaline phosphatase Fab fragment (11093274910, Roche) diluted in TBST (1:1000) at 4°C overnight. The following day, the sections were washed with TBST for 2 hours at room temperature and the alkaline phosphatase activity was detected with nitro-blue tetrazolium (N6639, Sigma) and 5-bromo-4-chloro-3′-indolyphosphate (B6149, Sigma).

For whole mount in situ hybridization, fixed lungs were separated into individual lobes, dehydrated and stored in 100% methanol at −20°C. For some riboprobes, E17 lungs were sliced at 200\~300 um thickness orthogonal to the main bronchi of the left and right caudal lobes with a micro-scissor to increase permeability. At room temperature, the lungs were rehydrated through a methanol/DEPC-PBS (diethylpyrocarbonate treated PBS) gradient, permeabilized with 20 ug mL^−1^ protease K (03115887001, Roche) in DEPC-PBS for 10 minutes and fixed with PBS with 0.25% glutaraldehyde and 4% PFA for 20 minutes. After incubation with pre-hybridization solution (50% formamide, 4x SSC, 1X Denhardt's solution, 250 ug uL^−1^ salmon sperm DNA, 250 ug uL^−1^ yeast tRNA, 50 ug mL^−1^ heparin, 0.1 % Tween-20) for 1 hour at 62°C, the sections were incubated with 1 ug mL^−1^ riboprobes diluted in hybridization solution (pre-hybridization solution with 10% \>500 kiloDalton dextran sulfate) in a slide oven (24100, Boekel) at 62°C overnight. The following day, the lungs were washed in 50% formamide with 4X SSC and 0.1% Tween-20 for 1 hour at 65°C, incubated with 100 ug mL^−1^ RNase A diluted in 100 mM Tris (pH 7.5) with 500 mM sodium chloride and 0.1% Tween-20 for 1 hour at 37°C, and then washed in 50% formamide with 2X SSC and 0.1% Tween-20 at 65°C overnight. The following day, the lungs were blocked with TBST with 5% normal sheep serum and then incubated with anti-digoxigenin alkaline phosphatase Fab fragment diluted in TBST at room temperature for 3 hours and subsequently washed in TBST at 4°C overnight. The following day, the alkaline phosphatase activity was detected with nitro-blue tetrazolium and 5-bromo-4-chloro-3′-indolyphosphate. After the alkaline phosphatase reaction, the lungs were fixed with 4% PFA in PBS at 4°C overnight, cleared with 75% glycerol and mounted on a depression well slide with cover slip for imaging. To minimize experimental variation, E14 and E17 lungs were embedded in the same OCT block and processed on the same section, and E14 lung lobes and E17 lung lobes or slices, and littermate control and mutant lung lobes were processed in the same tube for each riboprobe throughout the in situ experiment. Images were captured on an upright microscope (BX60, Olympus) or a stereomicroscope (M80, Leica).

Lung explant culture {#S17}
--------------------

E13 lungs or E14 lung slices of 200\~300 um thickness were isolated in ice-cold PBS and cultured on Whatman polycarbonate membranes (09-300-53, Fisher Scientific) in DMEM/F12 media (11320032, Invitrogen) with 1% fetal bovine serum (16140063, Invitrogen) and penicillin and streptomycin (15140148, Invitrogen). To activate *Sftpc*-*rtTA*, 2 ug mL^−1^ doxycycline was added to the culture media. To screen for hormonal regulators of BADJ formation, the following chemicals were added to the culture media: dexamethasone (100 nM, D2915, Sigma), 6-propyl-2-thiouracil (100 uM, P3755, Sigma), methimazole (50 uM, M8506, Sigma), and acitretin (10 uM, 44707, Sigma), mifepristone (3 uM, M8046, Sigma). Cultured lungs were imaged daily on a fluorescence stereomicroscope (M205C, Leica).

Microarray expression profiling {#S18}
-------------------------------

RNAs were extracted from E14 lungs cultured in control and dexamethasone media for 24 hours using Trizol reagents (15596018, Invitrogen) and an RNeasy Mini kit (74104, Qiagen). Labeled cRNAs were generated using an Illumina TotalPrep RNA amplification kit (AMIL1791, Invitrogen) and hybridized to Illumina mouse WG-6 v2 expression beadchips (BD-201-0202, Illumina). The experiments were repeated with lungs from independent litters. The expression values from the microarrays were normalized using rank invariant normalization and analyzed using the R statistical software.
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![Three dimensional definition of the BADJ in the mature mouse lung\
(**a**) Stereomicroscope images of a whole mount immunostained cranial lung lobe from a 4-week old mouse. SMA, Smooth muscle actin; CCSP, Clara cell secretary protein. The boxed areas are enlarged in subsequent images. The conducting airways marked by SOX2 expression are traced with white dashed lines, and the BADJs, marked by the distal boundaries of SOX2 and CCSP expression domains, on the front and back sides of the tube are traced with solid and dashed red lines, respectively. The airway smooth muscles are traced with green dashed lines and the vascular smooth muscles are traced with solid green lines. The diagram illustrates significant irregularity in the shape of the BADJ around the perimeter of a terminal bronchiole. Conducting airway cells in the front (black) and back (grey) sides of the tube and the associated BADJs (solid and dashed red lines) are drawn. Scale: 250 um. (**b**) Confocal images of immunostained sections of a 4-week old mouse lung. ECAD, E-Cadherin; SFTPC, Surfactant protein C; RAGE, Receptor for advanced glycosylation of end products. Insets, SOX2 staining only. The boxed areas are enlarged in subsequent images. Some BADJs harbor 1\~2 cells (arrowheads) with low level of SOX2 expression that also express SFTPC and may represent the BASCs. The diagram illustrates the difference in morphology and arrangement between cells in the conducting airways (filled red nuclei) and gas exchange region (black nuclei). Cells with open red nuclei represent the BASCs at the BADJ. Scale: 20 um. (**c**) Confocal images of an immunostained section of a 4-week old mouse lung showing that, depending on the local shape of the BADJ and the section plane (left diagram, the conducting airway in red), a conducting airway that is continuous in 3D can appear interrupted by alveolar type I and type II cells (brackets) on section (right diagram, see (**b**) for symbol definition). One side of the tube is diagramed and traced with long dashed lines, and the boxed area is enlarged in subsequent images. DIC, differential interference contrast. Scale: 20 um.](nihms587970f1){#F1}

![A first wave generates both epithelial compartments\
(**a**) Optical projection tomography (OPT) images of whole mount immunostained lungs. All whole embryonic lungs and the P18 left lobe are shown to the same scale (Scale: 500 um) with the exception of the E10 foregut and E11 lung, which are shown at a higher magnification (Scale: 100 um). In a side view of the E10 foregut, the nascent left lung bud (left) is outlined with a dashed line. The L.L2 branch lineages ^[@R14]^ are traced with dashed lines, and shown as inset for the P18 lung and separately for the embryonic lungs (right panels, Scale: 500 um). Double-sided arrows indicate that the gap between the distal boundaries of the SOX2 and SOX9 expression domains widens after E17. Due to variation in the branch lineage ^[@R14]^, BADJ formation (closed arrowheads) are inferred by counting branches (**b**) and from lineage tracing experiments. Asterisks indicate background staining from blood vessels only present in older postnatal lungs. Lower left panels (Scale: 100 um): projection of confocal images of immunostained E17 and E19 lung lobe edges for a high resolution view of SOX9 positive branch tips (dashed line). (**b**) Quantification of the number of SOX9 positive branch tips (green circle) and SOX2 positive branch termini (red cross) of the planar bifurcation of L.L1 through L.L6 branch lineages ^[@R14]^. The number of SOX2 positive termini plateaus at E17 (closed arrowhead). The number of SOX9 positive tips reaches the maximal number of SOX2 positive termini at E15 (open arrowhead). (**c**, **e**) Whole mount in situ hybridization of lungs at E14 (early branches) and E17 (late branches) for markers of simple epithelium (*Krt8*, *Krt18*, (**c**)) and branching related genes identified in an in silico screen of Eurexpress ^[@R69]^ (**e**). Branch tips are outlined with dashed lines. Scale: 20 um. (**d**) Confocal images of whole mount immunostained lungs at E14 (early branches) and E17 (late branches). pERK, phosphorylated Extracellular signal-Related Kinase. pERK-positive branch tips are outlined with dashed lines. Cells in the vasculature are also pERK positive (arrowheads). Scale: 20 um.](nihms587970f2){#F2}

![A second wave establishes the BADJ\
(**a**) Stereomicroscope images of whole mount immunostained cranial lobes. Lineage labeling is induced with tamoxifen (Tam) at indicated embryonic days. The distal boundaries of GFP expressing cells (lineage markers) and those of SOX2 expressing cells (BADJs) are marked by red dashed lines and white arrowheads, respectively. The conducting airways along the RCr.L1 lineage ^[@R14]^ are divided into three regions of equal length (I, II and III) and representative high magnification images of GFP expressing cells in each region are shown (right column). No alveolar cells are lineage-labeled. Asterisks indicate non-specific staining due to antibody trapping. Scale: 1000 um (left and middle columns) and 20 um (right column). (**b**) Two-wave model superimposed by the *Sox2^CreER^* lineage tracing schematics. Branches are generated by the first wave of branching morphogenesis (green dashed curves connected with green arrows) with SOX9-positive tips (green). Branches generated early (before E15), but not late (after E17), activate SOX2 expression (red) and constitute the second wave of conducting airway differentiation (red dashed curves connected with red arrows). The BADJ forms (arrowhead) when the second wave terminates at E17. The most proximal portions of the respiratory tree are SOX2-positive branched structures at E13 and are shown as red vertical lines for simplicity (square bracket I). The predicted distributions of *Sox2^CreER^*-lineage cells labeled at E13 (square), E15 (triangle) and E17 (circle) are shown along the respiratory trees. The three portions (I, II and III) in the mature (P21) airways (**a**) are illustrated on the schematics of the E19 lung. (**c**) Percentage of labeled cells at indicated positions (I, II and III) relative to those in the extra-pulmonary bronchus of the same lung that have been lineage labeled at E13 (square), E15 (triangle) and E17 (circle). H: high (67--100%), M: medium (33--67%), L: low (0--33%). (**d**) Stereomicroscope images of a whole mount immunostained P21 lung lineage-labeled at E17. The conducting airways are traced with white dashed lines, and the BADJs at the front and back of the branch are marked with solid and dashed red lines, respectively. The lineage labeled cells at the BADJ are marked with horizontal carets. Scale: 20 um.](nihms587970f3){#F3}

![Role of candidate morphogens in the progression of the two waves\
(**a**) OPT images of whole mount immunostained E15 (left panels) and E18 (right panels) lungs from littermate embryos that have been injected with tamoxifen (Tam) at E12 and E15, respectively. The boxed regions are shown as a section view for E15 and as a projection view for E18. Stereomicroscope images are shown as insets for ECAD staining at E18 for higher resolution. The accessory lobes of E18 *Kras^LSL-G12D/+^; Sox9^CreER/+^* lungs are removed for clarity. The first (SOX9) wave is affected similarly at both time points, including formation of overgrown branches (asterisk) with expanded SOX9 expression in the *Kras* mutant and loss of SOX9 expression (open green arrowhead) in the *Ctnnb1* mutant. The second (SOX2) wave is affected at E15 when its progression has been coupled with the first wave, including a restricted (open arrow) or expanded (open arrowhead, also limited SOX2-negative ECAD region in the E15 whole lung image) SOX2 expression domain in the *Kras* or *Ctnnb1* mutants, respectively. At least two independent experiments for each time point are performed with similar results. Scale: 200 um. (**b**) In situ hybridization (left panels) and OPT images (right panels) of whole mount lungs from littermate embryos. Scale: 400 um.](nihms587970f4){#F4}

![BADJ formation is independent of branch size and generation\
(**a**, **b**) OPT images of whole mount immunostained lungs from *Sftpc-rtTA; TetO-DTA* (treated with doxycycline from E13 to E14) or *Igf1r^−/−^* mutant and their respective littermate control embryos. The L.L6 branch lineages ^[@R14]^ in the boxed areas are enlarged and traced with dashed lines in subsequent images. At least two experiments for each time point are performed with similar results. As illustrated in the diagram (**c**), in the *Sftpc-rtTA; TetO-DTA* and *Igf1r^−/−^* mutant lungs, the first wave is still marked by SOX9 expression but progresses much slower than that in the control lungs; and the second wave follows the first wave early in development and terminates on schedule at E17.](nihms587970f5){#F5}

![Premature activation of glucocorticoid signaling causes a proximal shift in BADJ location in culture and in vivo\
(**a**) Stereomicroscope images of lung slices from an E14 *Sox2^EGFP/+^; Rosa^tdT/+^; Shh^Cre/+^* embryo at the beginning of the culture (E14+0div) or cultured for 1 (1div) or 2 (2div) days in the absence (Control) or presence (Dexamethasone) of dexamethasone. Arrowheads indicate the distal boundary of the *Sox2^EGFP^* expression domain. To keep a consistent color scheme, the green fluorescence from *Sox2^EGFP/+^* and the red fluorescence from *Rosa^tdT/+^; Shh^Cre/+^* are pseudo-colored red and blue, respectively. div, days in vitro. Scale: 200 um. (**b**, **c**) OPT images of E15 whole mount immunostained lungs (**b**, scale: 500 um) and confocal images of E15 immunostained lung sections (**c**, scale: 20 um) from control embryos or embryos treated with dexamethasone in drinking water from E12 in vivo. Arrowheads indicate the distal boundary of the SOX2 expression domain. The numbers of SOX2-positive termini (red number, p=0.002, Student's t-test) or SOX9-positive (green number, p=0.56, Student's t-test) tips from three lungs (the first number corresponding to the lung shown) are quantified. The epithelia are traced with dashed lines and the boxed areas are enlarged in subsequent images. There is a very low level of RAGE expression and no AQP1 expression in the control epithelium. Asterisks indicate normal expression of AQP1 in the vasculature. The teratogenic effects of dexamethasone limit the extent of signaling activation in vivo and restrict the sizes of the embryo and the lung.](nihms587970f6){#F6}

![Loss of glucocorticoid activity causes a distal shift in BADJ location\
(**a**) OPT images of whole mount immunostained lungs. Arrowhead, distal boundary of the SOX2 expression domain. The numbers of SOX2-positive termini (red number, p=0.0008, Student's t-test) or SOX9-positive (green number, p=0.8, Student's t-test) tips from three lungs (the first number corresponding to the lung shown) are quantified. The L.L1.A4 branch lineages ^[@R14]^ in the boxed areas are enlarged and traced with dashed lines in subsequent images. The accessory lobes are removed for clarity. The asterisk indicates blood auto-fluorescence. Scale: 500 um. (**b**) Confocal images of immunostained lungs. CCND1, Cyclin D1. Left panels: white lines, conducting airways; filled arrowheads, BADJs; open arrowheads, branch tips. The *GR* mutant has larger SOX9-positive branch tips shown in a stack projection view on the left and as a result has more recognizable branch tips on a section view on the right. Right panels: The boxed areas are enlarged in subsequent images. Note that non-epithelial cells also express CCND1. Scale: 20 um. (**c**) Diagrams illustrating that BADJ formation is specified by a temporal mechanism. The first wave of branching morphogenesis (the SOX9 wave) persists throughout embryonic development (green arrow). The second wave of conducting airway differentiation (the SOX2 wave) follows the first wave, prospectively marks the conducting airways, and terminates at E17 (red arrow), after which the differentiation of gas exchange region begins (black arrow). Cells near the BADJ are generated at E15 by the SOX9 wave (open arrowhead) and the BADJ forms at E17 after the SOX2 wave terminates (closed arrowhead). Long dashed lines connecting the two waves show the temporal delay between branch generation and SOX2 expression. A low level of SOX2 expression is present in part of the main bronchi at E11. An increase in glucocorticoid signaling (light blue arrow) coincides temporally with BADJ formation and premature activation of glucocorticoid signaling (Dexamethasone) terminates the second wave early and causes a proximal shift in BADJ location. Loss of GR prolongs the second wave and causes a distal shift in BADJ location associated with defects in alveolar differentiation (dashed black arrow) and SOX9-positive progenitor cell maintenance (green dashed arrow).](nihms587970f7){#F7}

[^1]: These authors contributed equally.
